Company Johnson & Johnson Berne S.E.

Equities

000943981

US4781601046

Pharmaceuticals

End-of-day quote Berne S.E. 03:30:00 12/06/2024 am IST 5-day change 1st Jan Change
131.9 CHF +0.55% Intraday chart for Johnson & Johnson -0.32% +0.35%

Business Summary

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows:

- pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.;

- medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals;

- consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc.

At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25).

Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).

Number of employees: 131,900

Sales per Business

USD in Million2022Weight2023Weight Delta
Innovative Medicine
64.3 %
52,563 55.4 % 54,759 64.3 % +4.18%
MedTech
35.7 %
27,427 28.9 % 30,400 35.7 % +10.84%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
54.5 %
48,580 51.2 % 46,444 54.5 % -4.40%
Europe
24.0 %
23,449 24.7 % 20,410 24.0 % -12.96%
Asia-Pacific, Africa
16.2 %
16,789 17.7 % 13,756 16.2 % -18.07%
Western Hemisphere Excluding United States
5.3 %
6,125 6.5 % 4,549 5.3 % -25.73%

Managers

Managers TitleAgeSince
Chief Executive Officer 61 01/89/01
Director of Finance/CFO 57 01/98/01
Chief Tech/Sci/R&D Officer 58 05/19/05
Chief Tech/Sci/R&D Officer 74 01/07/01
Investor Relations Contact - 01/21/01
Corporate Officer/Principal - -
Corporate Officer/Principal - -
Corporate Officer/Principal 47 01/19/01
Corporate Officer/Principal 52 -
General Counsel 53 01/06/01

Members of the board

Members of the board TitleAgeSince
Director/Board Member 70 25/19/25
Director/Board Member 72 19/14/19
Director/Board Member 70 22/09/22
Director/Board Member 64 05/19/05
Director/Board Member 60 15/13/15
Chief Executive Officer 61 01/89/01
Director/Board Member 58 15/22/15
Director/Board Member 59 30/11
Director/Board Member 62 05/19/05
Director/Board Member 63 03/20/03

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,119,799,183 2,404,640,893 ( 77.08 %) 713,120,000 ( 22.86 %) 77.08 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
9.513 %
228,938,504 9.513 % 33 578 M CHF
BlackRock Advisors LLC
6.055 %
145,731,837 6.055 % 21 374 M CHF
133,519,781 5.548 % 19 583 M CHF
Geode Capital Management LLC
2.216 %
53,322,964 2.216 % 7 821 M CHF
Eaton Vance Management
1.768 %
42,549,943 1.768 % 6 241 M CHF
BlackRock Life Ltd.
1.557 %
37,465,814 1.557 % 5 495 M CHF
State Farm Investment Management Corp.
1.316 %
31,675,492 1.316 % 4 646 M CHF
JPMorgan Investment Management, Inc.
1.218 %
29,309,544 1.218 % 4 299 M CHF
Wells Fargo Bank NA
1.133 %
27,263,857 1.133 % 3 999 M CHF
Norges Bank (13F)
1.079 %
25,977,042 1.079 % 3 810 M CHF
NameEquities%Valuation
BB Gestão de Recursos DTVM SA
0.000638 %
230,549 0.000638 % 2 M CHF
Itaú Unibanco SA
0.000452 %
163,187 0.000452 % 2 M CHF
Safra Asset Management Ltda.
0.000272 %
98,400 0.000272 % 962 311 CHF
Bram Bradesco Asset Management S/A DTVM
0.000210 %
75,910 0.000210 % 742 368 CHF
Caixa DTVM SA
0.000105 %
38,022 0.000105 % 371 839 CHF
XP Allocation Asset Management Ltda.
0.000039 %
13,915 0.000039 % 136 083 CHF
Warren Brasil Gestão e Administração e Recursos Ltda.
0.000027 %
9,686 0.000027 % 94 725 CHF
Western Asset Management Company DTVM Ltda.
0.000001 %
221 0.000001 % 2 161 CHF

Holdings

NameEquities%Valuation
182,329,550 9.52% 3,518,960,315 $
810,170 0.51% 84,484,528 $
2,449,183 4.18% 68,944,501 $
5,623,816 11.93% 39,591,665 $
814,586 0.45% 32,591,586 $
6,641,064 10.33% 32,541,214 $
1,979,173 10.42% 30,320,930 $
4,103,430 19.00% 28,518,839 $
9,581,882 5.07% 27,551,264 $
357,939 0.70% 23,767,150 $

Company contact information

Johnson & Johnson

One Johnson & Johnson Plaza

08933, New Brunswick

+732 524 0400

http://www.jnj.com
address Johnson & Johnson(000943981)

Group companies

NameCategory and Sector
Medical Specialties
Pharmaceuticals: Major
Electronic Components
Medical Specialties
Pharmaceuticals: Major
Pharmaceuticals: Major
Household/Personal Care
Pharmaceuticals: Major
Medical Specialties

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
145.4 USD
Average target price
171.7 USD
Spread / Average Target
+18.09%
Consensus
1st Jan change Capi.
+50.38% 78TCr
+18.66% 33TCr
+7.50% 29TCr
+16.91% 25TCr
+0.53% 22TCr
+11.06% 22TCr
+3.61% 16TCr
-3.91% 16TCr
-2.04% 12TCr
Other Pharmaceuticals